Med. praxi. 2013;10(5):199-202

Vitamin D: skeletal and extraskeletal effects

prof.MUDr.Vladimír Palička, CSc.
Osteocentrum, ÚKBD, LF UK a FN Hradec Králové

Vitamin D is among the oldest physiological regulators of the body's development and function. The view on its role in healthy skeletal

development – and in the occurrence of rachitis due to its lack – has recently expanded significantly. The pathophysiological background

of the mechanism of action of vitamin D on bone tissue (the RANKL/RANK/OPG system) is known in much more detail. Of interest is the

new knowledge of the effect of vitamin D on cardiovascular system and vessel impairment as well as its impact on the renin-angiotensin

system. The part that vitamin D plays in insulin secretion and peripheral sensitivity to insulin as well as in the development of obesity and

metabolic syndrome is obvious. The role of vitamin D in innate and acquired immunity and also in the development of autoimmune disease

is indisputable and the papers on the role of vitamin D in tumour proliferation are intriguing.

Keywords: vitamin D, rachitis, osteomalacia, cardiovascular disease, tumours, diabetes mellitus, immunity

Published: June 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Palička V. Vitamin D: skeletal and extraskeletal effects. Med. praxi. 2013;10(5):199-202.
Download citation

References

  1. Pike JW, Zella LA, Meyer MB, Fretz JA, Kim S. Molecular Actions of 1,25-Dihydroxyvitamin D3 on Genes Involved in Calcium Homeostasis. J Bone Miner Res. 2007; 22/S-2, V16-V19. Go to original source... Go to PubMed...
  2. Heaney RP. Vitamin D Endocrine Physiology. J Bone Miner Res. 2007; 22/S-2, V25-V27. Go to original source... Go to PubMed...
  3. Cavalier E, Delanaye P, Chapelle JP, Souberbielle JC. Vitamin D: current status and perspectives. Clin Chem Lab Med. 2009; 47(2): 120-127. Go to original source... Go to PubMed...
  4. Hollis BW, Wagner CL. Vitamin D and Pregnancy: Skeletal Effects, Nonskeletal Effects, and Birth Outcomes. Calcif Tissue Int. 2013; 92(2): 128-139. Go to original source... Go to PubMed...
  5. Winzenberg T, Jones G. Vitamin D and Bone Health in Childhood and Adolescence. Calcif Tissue Int. 2013; 92(2): 140-150. Go to original source... Go to PubMed...
  6. Olmos JM, Hernández JL, Llorca J, Nan D, Valero C, González-Macías J. Effects of 25-Hydroxyvitamin D3 Therapy on Bone Turnover Markers and PTH Levels in Postmenopausal Osteoporotic Women Treated with Alendronate. J Clin Endocrinol Metab. 2012; 97(12): 4491-4497. Go to original source... Go to PubMed...
  7. Zhang Y, Post WS, Dalal D, Bansal S, Blasco-Colmenares E, De Beur SJ, Alonso A, Soliman EZ, Whitsel EA, Brugada R, Tomaselli GF, Guallar E. Serum 25-Hydroxyvitamin D, Calcium, Phosphorus, and Eelctrocardiographic QT Interval Duration: Findings from NHANES III and ARIC. J Clin Endocrinol Metab. 2011; 98(6): 1873-1882. Go to original source... Go to PubMed...
  8. Farahnak P, Lärfars G, Sten-Linder M, Nilsson IL. Mild Primary Hyperparathyroidism: Vitamin D Deficiency and Cardiovascular Risk Markers. J Clin Endocrinol Metab. 2011; 96(7): 2112-2118. Go to original source... Go to PubMed...
  9. Pilz S, Kienreich K, Tomaschitz A, Lerchbaum E, Meinitzer A, März W, Zittermann A, Dekker JM. Vitamin D and cardiovascular disease: Update and outlook. Scand J Clin Lab Invest. 2012; 72(Suppl 243): 83-91.
  10. Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism Clin Exp. 2012; 61(4): 450-458. Go to original source... Go to PubMed...
  11. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM. Vitamin D3 Supplementation Has No Effect on Conventional Cardiovascular Risk Factors: A Parallel-Group, Double-Blind, Placebo-Controlled RCT. J Clin Endocrinol Metab. 2012; 97/10: 3557-3568. Go to original source... Go to PubMed...
  12. Lim S, Shin H, Kim MJ, Ahn HY, Kang SM, Yoon JW, Choi SH, Kim KW, Song JH, Choi SI, Chun EJ, Shin ChS, Park KS, Jang HCh. Vitamin D Inadequacy Is Associated with Significant Coronary Artery Stenosis in a Community-Based Elderly Cohort: The Korean Longitudinal Study on Health and Aging. J Clin Endocrinol Metab. 2012; 97(1): 169-178. Go to original source... Go to PubMed...
  13. Giallauria F, Milaneschi Y, Tanaka T, Maggio M, Canepa M, Elango P, Vigorito C, Lakatta EG, Ferrucci L, Strait J. Arterial Stiffness and Vitamin D Levels: the Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2012; 97(10): 3717-3723. Go to original source... Go to PubMed...
  14. Vaidya A, Willims JS. Vitamin D and insulin sensitivity: can gene association and pharmacogenetic studies of the vitamin D receptor provide clarity? Metabolism Clin Exp. 2012; 61(6): 759-761. Go to original source... Go to PubMed...
  15. Renzaho AMN, Halliday JA, Nowson C. Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: A systematic review. Nutrition 2011; 27(9): 868-879. Go to original source... Go to PubMed...
  16. Grethen E, McClintock R, Gupta ChE, Jones R, Cacucci BM, Diaz D, Fulford AD, Perkins SM, Considine RV, Peacock M. Vitamin D and Hyperparathyroidism in Obesity. J Clin Endocrinol Metab. 2011; 96(5): 1320-1326. Go to original source... Go to PubMed...
  17. Nimitphong H, Holick MF, Fried SK, Lee MJ. 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 Promote the Differentiation of Human Subcutaneous Preadipocytes. PLoS One 2012; 7(12): e52171. Go to original source... Go to PubMed...
  18. Afzal S, Bojesen SE, Nordestgaard BG. Low 25-Hydroxyvitamin D and Risk of Type 2 Diabetes: A Prospective Cohort Study and Metaanalysis. Clin Chem. 2013; 59(2): 381-391. Go to original source... Go to PubMed...
  19. Thomas MC, Cooper ME. Into the light? Diabetic nephropathy and vitamin D. Lancet 2010; 376(9752): 1521-1522. Go to original source... Go to PubMed...
  20. Welsh J. Vitamin D and cancer: Integration of cellular biology, molecular mechanisms and animal models. Scand J Clin Lab Invest. 2012, 72(Suppl 243): 103-111.
  21. Manson JE, Mayne ST, Clinton SK. Vitamin D and Prevention of Cancer - Ready for Prime Time? N Engl J Med. 2011; 364(15): 1385-1387. Go to original source... Go to PubMed...
  22. Hewison M. Vitamin D and immune function: Autocrine, paracrine or endocrine? Scand J Clin Lab Invest. 2012; 72(Suppl 243): 92-102.
  23. Fulgheri G, Malinowski B, Bergmann K. Association Between Vitamin D Deficiency and Allergic Diseases. eJIFCC 2011; 22(2): 1-6. Go to PubMed...
  24. Walker WP, Zhang X, Rastegar I, Liu PT, Hollis BW, Adams JS, Modlin RL. Cord Blood Vitamin D Status Impacts Innate Immune Responses. J Clin Endocrinol Metab. 2011; 96(6): 1835-1843. Go to original source... Go to PubMed...
  25. Dawson-Hughes B. What is the Optimal Dietary Intake of Vitamin D for Reducing Fracture Risk? Calcif Tissue Int. 2013; 94(2): 184-190. Go to original source... Go to PubMed...
  26. Sinha A, Cheetham TD, Pearce SHS. Prevention and Treatment of Vitamin D Deficiency. Calcif Tissue Int. 2013; 92(2): 207-215. Go to original source... Go to PubMed...
  27. Vieth R. Vitamin D Toxicity, Policy, and Science. J Bone Miner Res. 2007; 22(Suppl 2): V64-V68. Go to original source... Go to PubMed...
  28. Glade MJ. Vitamin D: panacea or false prophet? Nutrition 2013; 29(1): 37-41. Go to original source... Go to PubMed...
  29. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving H-H, Pritchett Y, Remuzzi G, Ritz E, Andress D. Selective vitamin D receptor activation with paracalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010; 376(9752): 1543-1551. Go to original source... Go to PubMed...
  30. Rajaskumar K, de las Heras J, Chen TC, Lee S, Holick MF, Arslanian SA. Vitamin D Status, Adiposity, and Lipids in Black American and Caucasian Children. J Clin Endocrinol Metab. 2011; 96(5): 1560-1567. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.